Clinical trial
Analysis of the Effectiveness and Safety of Endoscopic Retrograde Cholangiopancreatography Versus Percutaneous Transhepatic Biliary Drainage in Severe Acute Cholangitis Caused by Common Bile Duct Stones
NCT07064980 is registered in ClinicalTrials.gov with Wuhan Integrated Traditional Chinese and Western Medicine Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of the Effectiveness and Safety of Endoscopic Retrograde Cholangiopancreatography Versus Percutaneous Transhepatic Biliary Drainage in Severe Acute Cholangitis Caused by Common Bile Duct Stones
- Lead sponsor
- Wuhan Integrated Traditional Chinese and Western Medicine Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2021
- Completion date
- May 31, 2024
- Enrollment
- 126 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe acute cholangitis